Background and study aims: Side-branch intraductal papillary mucinous neoplasms (SB-IPMNs), and associated synchronous and metachronous pancreatic cancers are increasingly detected as imaging modalities become more sensitive. We investigated the natural history of SB-IPMN, and the incidence and characteristics of pancreatic cancers among patients undergoing long-term follow-up.
Patients and methods: We reviewed the clinical, imaging, and pathological features in 103 patients, diagnosed at the Aichi Cancer Center between September 1988 and September 2006 as having SB-IPMN, and conservatively followed up for ≥ 2 years (median 59 months) based on an endoscopic ultrasonography (EUS) database.
Results: 74 (71.8 %) patients had nonprogressive lesions. Overall, six patients (5.8 %) developed pancreatic cancers during follow-up, with intraductal papillary mucinous (IPM) carcinoma in four, and ductal carcinoma of pancreas that was not IPMN in two patients. Of the six pancreatic cancers, five were diagnosed at a resectable stage. The 5-year and 10-year actuarial rates of development of pancreatic cancer were 2.4 % and 20.0 %, respectively. Although, at the last follow-up, cyst size, main pancreatic duct (MPD) diameter, mural nodule size, and frequency of metachronous and/or synchronous cancers of other organs were significantly higher in patients who developed IPM carcinoma, resected SB-IPMNs without mural nodules and dilated MPDs had no IPM carcinomas.
Conclusions: The frequency of pancreatic cancers is high on long-term follow-up of SB-IPMN. Although conservative management is appropriate for selected patients, regular and long-term imaging, especially by EUS is essential, even if SB-IPMN remains unchanged for 2 years. Presence of mural nodule and dilated MPD seem to be more appropriate indicators for resection than cyst size alone for SB-IPMNs.
References
-
1
Ohhashi K, Murakami Y, Maruyama M. et al .
Four cases of mucous secreting pancreatic cancer [in Japanese].
Prog Dig Endosc.
1982;
20
348-351
-
2 Kloppel G, Solcia E, Longnecker D S. et al .World Health Organization international histological classification of tumors. Histological typing of tumors of the exocrine pancreas. 2nd edn. Berlin; Springer 1996
-
3 Solcia E, Capella C, Kloeppel G. Tumors of the pancreas. In: Rosai J, ed Atlas of tumor pathology. Fascicle 20. Washington; Armed Forces Institute of Pathology 1997: 31-144
-
4 Yamao K, Nakazawa S, Fujimoto M. et al .Intraductal papillary tumors, non-invasive and invasive. In: Pour PM, Konishi Y, Kloppel G, Longnecker DS, eds Atlas of exocrine pancreatic tumors. Tokyo; Springer 1994: 43-66
-
5
Azar C, Van de Stadt J, Rickaert F. et al .
Intraductal papillary mucinous tumours of the pancreas. Clinical and therapeutic issues in 32 patients.
Gut.
1996;
39
457-464
-
6
Loftus E V, Olivares-Pakzad B A, Batts K P. et al .
Intraductal papillary-mucinous tumors of the pancreas: clinicopathological features, outcome, and nomenclature.
Gastroenterology.
1996;
110
1909-1918
-
7
Hruban R H, Takaori K, Klimstra D S. et al .
An illustrated consensus on the classification of pancreatic intraepithelial neoplasia and intraductal papillary mucinous neoplasms.
Am J Surg Pathol.
2004;
28
977-987
-
8
Furukawa T, Kloppel G, Volkan Adsay N. et al .
Classification of types of intraductal papillary-mucinous neoplasm of the pancreas: a consensus study.
Virchows Arch.
2005;
447
794-799
-
9
Tanaka M, Chari S, Adsay V. et al .
International consensus guidelines for management of intraductal papillary mucinous neoplasms and mucinous cystic neoplasms of the pancreas.
Pancreatology.
2006;
6
17-32
-
10
Conlon K C.
Intraductal papillary mucinous tumors of the pancreas.
J Clin Oncol.
2005;
23
4518-4523
-
11
Wada K, Kozarek R A, William Traverso L.
Outcomes following resection of invasive and noninvasive intraductal papillary mucinous neoplasms of the pancreas.
Am J Surg.
2005;
189
632-636
-
12
Salvia R, Fernandez-del Castillo C, Bassi C. et al .
Main-duct intraductal papillary mucinous neoplasms of the pancreas: clinical predictors of malignancy and long-term survival following resection.
Ann Surg.
2004;
239
678-685
-
13
Yamaguchi K, Ohuchida J, Ohtsuka T. et al .
Intraductal papillary-mucinous tumor of the pancreas concomitant with ductal carcinoma of the pancreas.
Pancreatology.
2002;
2
484-490
-
14
Tada M, Kawabe T, Arizumi M. et al .
Pancreatic cancer in patients with pancreatic cystic lesions: a prospective study in 197 patients.
Clin Gastroenterol Hepatol.
2006;
4
1265-1270
-
15
Uehara H, Nakaizumi A, Ishikawa O. et al .
Development of ductal carcinoma of the pancreas during follow-up of branch duct intraductal papillary mucinous neoplasm of the pancreas.
Gut.
2008;
57
1561-1565
-
16
Tanno S, Nakano Y, Koizumi K. et al .
Pancreatic ductal adenocarcinomas in long-term follow-up patients with branch duct intraductal papillary mucinous neoplasms.
Pancreas.
2010;
39
36-40
-
17
Chari S, Yadav D, Smyrk T. et al .
Study of recurrence after surgical resection of intraductal papillary mucinous neoplasm of the pancreas.
Gastroenterology.
2002;
123
1500-1507
-
18
Ingkakul T, Sadakari Y, Ienaga J. et al .
Predictors of the presence of concomitant invasive ductal carcinoma in intraductal papillary mucinous neoplasm of the pancreas.
Ann Surg.
2010;
251
70-75
-
19 Japan Pancreas Society .Classification of pancreatic cancer. 6th edn. Tokyo, Japan; Kanehara 2009
-
20
Schmidt C M, White P B, Waters J A. et al .
Intraductal papillary mucinous neoplasms: predictors of malignant and invasive pathology.
Ann Surg.
2007;
246
644-651
-
21
Salvia R, Crippa S, Falconi M. et al .
Branch-duct intraductal papillary mucinous neoplasms of the pancreas: to operate or not?.
Gut.
2007;
56
1086-1090
-
22
Tanno R, Nakano Y, Nishikawa T. et al .
Natural history of branch duct intraductal papillary mucinous neoplasms of the pancreas without mural nodules: long term follow-up results.
Gut.
2008;
57
339-343
-
23
Sadakari Y, Ienaga J, Kiichiro K. et al .
Cyst size indicates malignant transformation in branch duct intraductal papillary mucinous neoplasm of the pancreas without mural nodules.
Pancreas.
2010;
39
232-236
-
24
Jang J Y, Kim S W, Ahn Y J. et al .
Multicenter analysis of clinicopathologic features of intraductal papillary mucinous tumor of the pancreas: is it possible to predict the malignancy before surgery?.
Ann Surg Oncol.
2005;
12
124-312
-
25
Baba T, Yamaguchi T, Ishihara T. et al .
Distinguish benign from malignant intraductal papillary mucinous tumors of the pancreas by imaging techniques.
Pancreas.
2004;
29
212-217
-
26
Yamaguchi K, Ogawa Y, Chijiiwa K. et al .
Mucin-hypersecreting tumors of the pancreas: assessing the grade of malignancy preoperatively.
Am J Surg.
1996;
171
427-431
-
27
Yamao K, Ohashi K, Nakamura T. et al .
Evaluation of various imaging methods in the differential diagnosis of intraductal papillary-mucinous tumor (IPMT) of the pancreas.
Hepatogastroenterology.
2001;
48
962-966
-
28
Sugiyama M, Atomi Y.
Extrapancreatic neoplasms occur with unusual frequency in patients with intraductal papillary mucinous tumors of the pancreas.
Am J Gastroenterol.
1999;
94
470-473
-
29
Osanai M, Tanno S, Nakano Y. et al .
Extrapancreatic neoplasms in patients with intraductal papillary tumors of the pancreas: analysis in surgical and follow up series [in Japanese with English abstract].
J Jpn Pancreas Soc.
2003;
18
5665-5669
-
30
Kamisawa T, Tu Y, Egawa N. et al .
Malignancies associated with intraductal papillary mucinous neoplasm of the pancreas.
World J Gastroenterol.
2005;
11
5688-5690
-
31
Lee S Y, Lee K T, Lee J K. et al .
Long-term follow up results of intraductal papillary mucinous tumors of pancreas.
J Gastroenterol Hepatol.
2005;
20
1379-1384
K. YamaoMD
Department of Gastroenterology
Aichi Cancer Center Hospital
1-1 Kanakoden, Chikusa-Ku
Nagoya 464-8681
Japan
Fax: +81-52-7642942
Email: kyamao@aichi-ac.jp